Monday, November 9, 2026

EUR/GBP Jumps By 1% In The Last 5 Sessions

EUR/GBP Jumps By 1% In The Last 5 Sessions

(VIANEWS) - EUR/GBP (EURGBP) has been up by 1.01% for the last 5 sessions. At 20:07 EST on Monday, 17 July, EUR/GBP (EURGBP) is $0.86.

EUR/GBP's yearly highs and lows, it's 3.082% up from its 52-week low and 6.919% down from its 52-week high.

Volatility

EUR/GBP's last week, last month's, and last quarter's current intraday variation average was a positive 0.06%, a negative 0.02%, and a positive 0.26%, respectively.

EUR/GBP's highest amplitude of average volatility was 0.38% (last week), 0.29% (last month), and 0.26% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/GBP's Forex is considered to be oversold (<=20).

News about

  • Eur/usd eases from multi-month high past 1.1200 as traders reconfirm fed bias. According to FXStreet on Sunday, 16 July, "Looking forward, second-tier activity and Retail Sales data from the US may entertain the EUR/USD traders amid the Fed blackout period, raising hopes of witnessing a pullback in prices.", "It should be noted that the recent industrial production and foreign trade numbers for the Eurozone haven't been supportive of the hawkish ECB bias and hence support the late EUR/USD retreat."
  • Eur/usd demonstrates volatile squeeze above 1.1200 as focus shifts to US retail sales. According to FXStreet on Monday, 17 July, "The EUR/USD pair has turned extremely choppy above the round-level resistance of 1.1200 in the Asian session. "
  • Eur/usd price analysis: Friday’s doji at multi-day top, overbought RSI tease euro bears below 1.1250. According to FXStreet on Monday, 17 July, "Also amplifying the odds of witnessing the pullback in the EUR/USD could be the RSI (14) conditions and a shift in the market sentiment, not to forget the reassessment of the Fed bias.", "In a case where the EUR/USD pair remains firmer past 1.1280, the odds of witnessing a run-up towards the February 2022 peak of around 1.1500 can't be ruled out."
  • According to FXStreet on Monday, 17 July, "The ongoing price action in EUR/USD hints at the idea that further gains might be in store in the short-term horizon. ", "Furthermore, the constructive view of EUR/USD appears unchanged as long as the pair trades above the key 200-day SMA."
  • According to FXStreet on Monday, 17 July, "Before that, the US Consumer Price Index (CPI) and Producer Price Index (PPI) for June dropped to 3.0% and 0.1% on a yearly basis from 4.0% and 0.9% YoY in that order, which in turn drowned the US Dollar and propelled the EUR/USD pair toward the highest level since February 2022."

More news about EUR/GBP (EURGBP).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Cycle: Data Readouts, FDA Decisions and Capital-Allocation Shifts
From late October to January, mid-cap biotechs move through a dense run of events: ESMO and AHA/AASLD data presentations, Q3 earnings, and FDA PDUFA dates for ivonescimab (Nov 14) and lorundrostat (Dec 22). Alongside the regulatory news, companies are changing how they allocate capital: one lowered FY2026 R&D and SG&A guidance and pushed milestones into 2027, one authorized a $400M buyback, and one scheduled a delisting vote (EGM Nov 19, application Jan 25). Value is concentrating in a few binary regulatory and Phase 3 outcomes (Maritime-1 and ECLIPSE 2/3 readouts around Q1 2027), so sentiment is mixed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,558 source documents archived
Query this data → isubstrate.com